He Meng

Title: He Meng: Innovator in Antibody Drug Conjugate Purification

Introduction

He Meng is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the purification of antibody drug conjugates. His innovative work has the potential to enhance the efficacy and safety of therapeutic agents.

Latest Patents

He Meng holds a patent for the "Purification of antibody drug conjugates using a sodium phosphate gradient." This patent describes methods for removing high molecular weight species, specifically aggregates, from antibody drug conjugate preparations. The process involves contacting preparations of the antibody drug conjugate reaction mixture with a hydroxyapatite resin and selectively eluting the ADC from the resin using a gradient comprising sodium phosphate. This innovation is crucial for improving the quality of antibody drug conjugates.

Career Highlights

He Meng is currently employed at Pfizer Corporation, a leading global biopharmaceutical company. His work at Pfizer focuses on advancing drug development processes and improving therapeutic outcomes through innovative purification techniques. His expertise in this area has positioned him as a valuable asset to the company.

Collaborations

He Meng collaborates with esteemed colleagues, including Durgesh Vasant Nadkarni and Jeffry R Borgmeyer. These collaborations foster a dynamic environment for innovation and contribute to the advancement of biopharmaceutical research.

Conclusion

He Meng's contributions to the field of antibody drug conjugate purification exemplify the impact of innovation in biopharmaceuticals. His patent and work at Pfizer Corporation highlight the importance of developing effective purification methods for therapeutic agents.